Savara's Grant

Savara raised a round of funding on June 11, 2010. Investors include Texas Emerging Technology Fund.

Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare res…

Articles about Savara's Grant: